Nuclide Therapeutics secures over $6 million for drugs against treatment-resistance cancers
 Nuclide Therapeutics, a King’s College London spinout developing radioactive drugs to target therapy-resistant cancers, has closed a…
Browsing Tag
Nuclide
1 post